Seattle Genetics, Inc. (Nasdaq:SGEN) today announced that its management will host a conference call and webcast on Monday, September 29, 2014, at 5:30 a.m. Pacific Time (PT) / 8:30 a.m. Eastern Time (ET) regarding top-line results from its ADCETRIS phase 3 AETHERA clinical trial for Hodgkin lymphoma patients at risk of relapse following autologous stem cell transplant. Help employers find you! Check out all the jobs and post your resume.
